Showing results (921-930 of 5,269) with videos related to

Sort By:
Pageof 527
European Journal of Haematology|September 9, 2017
Post-transplant consolidation plus lenalidomide maintenance vs lenalidomide maintenance alone in multiple myeloma: A systematic reviewFatimah Al-Ani, Martha Louzada
European Journal of Haematology|September 10, 2017
Dermatopathic lymphadenopathy with Langerhans cell chimerism in graft-versus-host disease of the skinAndreas Kreft, Kristina Krümpelmann, Andreas Rosenwald, et al.
European Journal of Haematology|October 17, 2017
A survey on hematology-oncology pediatric AIEOP centres: The challenge of posterior reversible encephalopathy syndromeDaniele Zama, Pietro Gasperini, Massimo Berger, et al.
European Journal of Haematology|September 13, 2017
Rapid reduction in BCR-ABL1 transcript predicts deep molecular response in dasatinib-treated chronic-phase chronic myeloid leukaemia patientsKazunori Murai, Kohei Yamaguchi, Shigeki Ito, et al.
European Journal of Haematology|May 6, 2016
Pembrolizumab in classical Hodgkin's lymphomaJoseph Maly, Lapo Alinari
European Journal of Haematology|September 1, 1987
Polyclonal B-cell activation after intravenous immunoglobulin therapy in idiopathic thrombocytopenic purpura--an anti-idiotype response?A G Wangel, M Lorenzetti, T Pettersson
European Journal of Haematology|October 27, 2020
Monitoring treatment response and disease progression in myeloma with circulating cell-free DNAShayu Deshpande, Ruslana G Tytarenko, Yan Wang, et al.
European Journal of Haematology|November 1, 1987
Monosomy 7 predisposes to diabetes insipidus in leukaemia and myelodysplastic syndromeA de la Chapelle, R Lahtinen
European Journal of Haematology|December 24, 2022
Desensitization protocol to lenalidomide: An effective and safe treatment modality for delayed hypersensitivity-induced rash in patients with multiple myelomaOded Shamriz, Elchanan Parnasa, Limor Rubin, et al.
European Journal of Haematology|December 27, 2022
Early-onset venous thromboembolisms in newly diagnosed non-promyelocytic acute myeloid leukemia patients undergoing intensive induction chemotherapySebastian E Koschade, Jan A Stratmann, Björn Steffen, et al.
Pageof 527